Pfizer is buying the cancer treatment company Array BioPharma in a deal worth more than $11 billion

NEW YORK (AP) — Pfizer is buying the cancer treatment company Array BioPharma in a deal worth more than $11 billion.

Read more on NewsOK.com

NEW YORK (AP) — Pfizer is buying the cancer treatment company Array BioPharma in a deal worth more than $11 billion.

Read more on NewsOK.com
Read more on Newsok 

Share Button

Leave a Reply

Your email address will not be published. Required fields are marked *